Tirzepatide may play a role in weight management in adults with T1D and obesity, even at low doses,” Jennifer R. Snaith, MD, ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and ...
BMJ Group announced its retraction of an analysis indicating that small daily amounts of apple cider vinegar may help produce ...
In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...
Preliminary results from the randomized phase 2 study (1801 part 3B) of elraglusib in combination with gemcitabine/nab-paclitaxel (GnP) versus GnP alone in patients ...
Hofseth Biocare ASA (($HOFBF)) announced an update on their ongoing clinical study. Hofseth Biocare ASA recently updated its clinical study titled ...
When compared to dulaglutide, Ozempic was associated with a reduced risk of major adverse cardiovascular events such as a heart attack or stroke by 23%. The results of the REACH study were recently ...
Semaglutide appears to provide a greater cardiovascular benefit vs dulaglutide in older T2D patients with ASCVD.
A large cohort study adds evidence that nicotinamide can prevent skin cancer in patients with previous skin cancers and solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback